THERAPEUTIC AGENT FOR DISC HERNIATION
    7.
    发明申请
    THERAPEUTIC AGENT FOR DISC HERNIATION 审中-公开
    治疗药物治疗药物

    公开(公告)号:US20170000863A1

    公开(公告)日:2017-01-05

    申请号:US15260286

    申请日:2016-09-08

    IPC分类号: A61K38/51

    摘要: The present invention provides a therapeutic agent for disc herniation, which has extremely few adverse side effects, can achieve a prolonged pain-ameliorating effect when administered in only a single dose, and can exhibit a high therapeutic effect and high safety in clinical applications. The present invention relates to a therapeutic agent for disc herniation, which is characterized by containing chondroitinase ABC as an active ingredient and being administered in such a manner that the ingredient can be administered into a human disk in an amount of 1-8 units per disk.

    摘要翻译: 本发明提供了一种椎间盘突出症治疗剂,其具有极少的副作用,仅在单一剂量下施用时可达到延长的疼痛改善效果,并且在临床应用中可表现出高治疗效果和高安全性。 椎间盘突出治疗剂本发明涉及椎间盘突出症治疗剂,其特征在于含有软骨素酶ABC作为活性成分,并且以这样的方式给药,使得该成分可以以每个盘1-8个单位的量施用于人体盘 。

    COMPOSITIONS AND METHODS OF USING CHONDROITINASE ABCI MUTANTS
    8.
    发明申请
    COMPOSITIONS AND METHODS OF USING CHONDROITINASE ABCI MUTANTS 有权
    组合物和使用CHONDROITINASE ABCI MUTANT的方法

    公开(公告)号:US20150322422A1

    公开(公告)日:2015-11-12

    申请号:US14790075

    申请日:2015-07-02

    IPC分类号: C12N9/88

    摘要: The present disclosure relates to protein and nucleic acid mutants of chondroitinase ABCI. Such nucleic acid mutants encode for chondroitinase ABCI mutant enzymes exhibiting altered chondroitin lyase activity or increased resistance to inactivation from stressors including UV light or heat. Methods of using such nucleic acid mutants encoding chondroitinase ABCI mutant enzymes is also provided.

    摘要翻译: 本公开涉及软骨素酶ABCI的蛋白质和核酸突变体。 这种核酸突变体编码表现出改变的软骨素裂解酶活性的软骨素酶ABCI突变体酶或增强的抗应激物包括UV光或热的对灭活的抗性。 还提供了使用编码软骨素酶ABCI突变酶的核酸突变体的方法。

    THERAPEUTIC AGENT FOR DISC HERNIATION
    9.
    发明申请
    THERAPEUTIC AGENT FOR DISC HERNIATION 审中-公开
    治疗药物治疗药物

    公开(公告)号:US20150071896A1

    公开(公告)日:2015-03-12

    申请号:US14491792

    申请日:2014-09-19

    IPC分类号: A61K38/51 A61K9/00

    摘要: The present invention provides a therapeutic agent for disc herniation, which has extremely few adverse side effects, can achieve a prolonged pain-ameliorating effect when administered in only a single dose, and can exhibit a high therapeutic effect and high safety in clinical applications. The present invention relates to a therapeutic agent for disc herniation, which is characterized by containing chondroitinase ABC as an active ingredient and being administered in such a manner that the ingredient can be administered into a human disk in an amount of 1-8 units per disk.

    摘要翻译: 本发明提供了一种椎间盘突出症治疗剂,其具有极少的副作用,仅在单一剂量下施用时可达到延长的疼痛改善效果,并且在临床应用中可表现出高治疗效果和高安全性。 椎间盘突出治疗剂本发明涉及椎间盘突出症治疗剂,其特征在于含有软骨素酶ABC作为活性成分,并且以这样的方式给药,使得该成分可以以每个盘1-8个单位的量施用于人体盘 。